Poggio et al. reported that exosomal PD-L1 systematically acts to suppress the anti-tumor immune response in prostate cancer, and its genetic blockage promotes T cell activity in draining lymph nodes to induce systemic anti-tumor immunity and memory (13). The gene discussed is CD274; the disease is prostate carcinoma.